Kovack Advisors Inc. Has $1.32 Million Position in Axon Enterprise, Inc (NASDAQ:AXON)

Kovack Advisors Inc. reduced its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 71.4% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 2,513 shares of the biotechnology company's stock after selling 6,281 shares during the quarter. Kovack Advisors Inc.'s holdings in Axon Enterprise were worth $1,322,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Brighton Jones LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at about $480,000. Teacher Retirement System of Texas purchased a new position in Axon Enterprise in the fourth quarter valued at approximately $399,000. LPL Financial LLC raised its holdings in Axon Enterprise by 13.5% in the fourth quarter. LPL Financial LLC now owns 101,431 shares of the biotechnology company's stock valued at $60,282,000 after buying an additional 12,052 shares during the period. FineMark National Bank & Trust purchased a new position in Axon Enterprise in the fourth quarter valued at approximately $255,000. Finally, TIAA Trust National Association lifted its position in shares of Axon Enterprise by 15.1% during the fourth quarter. TIAA Trust National Association now owns 1,457 shares of the biotechnology company's stock worth $866,000 after purchasing an additional 191 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 9,905 shares of Axon Enterprise stock in a transaction on Wednesday, May 21st. The stock was sold at an average price of $738.03, for a total transaction of $7,310,187.15. Following the completion of the transaction, the president directly owned 298,809 shares of the company's stock, valued at approximately $220,530,006.27. This trade represents a 3.21% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Caitlin Elizabeth Kalinowski sold 1,300 shares of the firm's stock in a transaction on Monday, May 19th. The shares were sold at an average price of $738.84, for a total value of $960,492.00. Following the completion of the sale, the director owned 4,829 shares of the company's stock, valued at approximately $3,567,858.36. This trade represents a 21.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,642 shares of company stock valued at $25,090,528 over the last 90 days. Corporate insiders own 4.40% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. JMP Securities boosted their price target on shares of Axon Enterprise from $725.00 to $825.00 and gave the company a "market outperform" rating in a report on Tuesday. UBS Group started coverage on shares of Axon Enterprise in a research note on Wednesday, July 16th. They set a "neutral" rating and a $820.00 target price on the stock. Wolfe Research initiated coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They issued an "outperform" rating on the stock. Finally, Needham & Company LLC boosted their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company's stock. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of "Moderate Buy" and an average price target of $772.08.

Axon Enterprise Stock Performance

Axon Enterprise stock traded up $25.75 during trading hours on Friday, reaching $735.01. 654,601 shares of the company were exchanged, compared to its average volume of 627,317. The firm has a market cap of $57.22 billion, a price-to-earnings ratio of 177.54, a PEG ratio of 79.06 and a beta of 1.29. The company has a current ratio of 2.83, a quick ratio of 2.62 and a debt-to-equity ratio of 0.68. The stock has a 50-day moving average of $763.82 and a 200 day moving average of $650.42. Axon Enterprise, Inc has a 12 month low of $279.02 and a 12 month high of $830.21.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The company had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same period in the previous year, the company earned $1.15 earnings per share. The company's quarterly revenue was up 31.3% compared to the same quarter last year. As a group, research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.